Free Trial

FY2026 EPS Estimates for Doximity Decreased by Analyst

Doximity logo with Medical background

Doximity, Inc. (NASDAQ:DOCS - Free Report) - Analysts at Leerink Partnrs dropped their FY2026 earnings per share estimates for Doximity in a research note issued to investors on Monday, May 12th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $1.17 per share for the year, down from their previous estimate of $1.19. Leerink Partnrs has a "Strong-Buy" rating on the stock. The consensus estimate for Doximity's current full-year earnings is $0.99 per share. Leerink Partnrs also issued estimates for Doximity's FY2027 earnings at $1.30 EPS and FY2028 earnings at $1.44 EPS.

A number of other research analysts have also commented on the company. Canaccord Genuity Group upped their price target on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research report on Friday, February 7th. Truist Financial dropped their price target on Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a research note on Thursday, April 10th. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and lifted their target price for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Mizuho raised their target price on Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Morgan Stanley lowered their price objective on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $65.39.

View Our Latest Stock Report on DOCS

Doximity Trading Down 1.1%

Doximity stock opened at $60.38 on Wednesday. The firm has a market cap of $11.27 billion, a P/E ratio of 60.38, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity has a 1-year low of $23.27 and a 1-year high of $85.21. The firm has a 50-day moving average of $57.71 and a 200-day moving average of $57.52.

Institutional Investors Weigh In On Doximity

Several institutional investors have recently modified their holdings of DOCS. Vanguard Group Inc. lifted its stake in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock valued at $707,646,000 after acquiring an additional 990,923 shares during the period. FMR LLC raised its holdings in shares of Doximity by 37.6% during the fourth quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after purchasing an additional 2,571,580 shares during the last quarter. Geode Capital Management LLC lifted its position in Doximity by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company's stock valued at $157,668,000 after purchasing an additional 95,458 shares during the period. Loomis Sayles & Co. L P boosted its holdings in Doximity by 2.7% in the fourth quarter. Loomis Sayles & Co. L P now owns 2,334,597 shares of the company's stock worth $124,644,000 after purchasing an additional 62,366 shares during the last quarter. Finally, Invesco Ltd. grew its position in Doximity by 54.8% in the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock worth $114,280,000 after purchasing an additional 696,923 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the transaction, the director now directly owns 16,618 shares of the company's stock, valued at approximately $946,062.74. This represents a 10.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 37.40% of the company's stock.

About Doximity

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines